This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Glaxosmithkline Intellectual Property Development Limited, University of Cambridge, Yale University. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 242 
1 out of 439 
1 out of 1,368 
Years Active: 2018-2020
Title: Afjal Hussain Miah: Innovator in Biopharmaceuticals
Introduction
Afjal Hussain Miah is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of biopharmaceuticals, holding a total of 4 patents. His work primarily focuses on developing innovative compounds and methods for treating diseases.
Latest Patents
One of his latest patents is titled "Conjugates comprising RIPK2 inhibitors." This invention relates to compounds, compositions, combinations, and medicaments that contain these compounds. It also discusses processes for their preparation and the use of these compounds as inhibitors of RIP2 kinase activity, particularly for treating inflammatory diseases. Another significant patent is "Compounds and methods for the enhanced degradation of targeted proteins and other polypeptides by an E3 ubiquitin ligase." This invention involves bifunctional compounds that act as modulators of targeted ubiquitination, specifically inhibiting various polypeptides and proteins. The compounds are designed to bind to a target protein and an E3 ubiquitin ligase, facilitating the degradation of the target protein.
Career Highlights
Afjal has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Development Limited and Yale University. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Throughout his career, Afjal has collaborated with notable colleagues such as John David Harling and Ian Edward David Smith. These partnerships have enriched his research and expanded the impact of his inventions.
Conclusion
Afjal Hussain Miah is a distinguished inventor whose work in biopharmaceuticals has led to significant advancements in the treatment of diseases. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile